Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IPIC -- Ignore unavailable to you. Want to Upgrade?

To: NeuroInvestment who wrote (1127)	3/31/1998 7:48:00 PM
From: Pancho Villa	Read Replies (1) \| Respond to of 1359

Neuro: I congratulate you for a most objective post! Currently I hold no position on IPIC. Just the type of perspective investors need to then make intelligent decisions. Pancho

To: NeuroInvestment who wrote (1127)	4/23/1998 11:24:00 AM
From: Grainne	Read Replies (1) \| Respond to of 1359

I am a little lost here, and hope you can provide a few words of wisdom. My main question is why the FDA would fast-track something and then there would be a disastrous study result so soon afterwards. Aren't the FDA doctors/scientists looking at efficacy before they decide to do that? The second question is how you feel at this point about the long-term prospects for IPIC. Although I have made money on this stock several times, the shares I currently hold were purchased at 37, so if there is a good possibility of recovery and profitability over a time frame of a few years, I would probably continue to hold. Thanks in advance for your expert opinion!!